Perrine Crequit, MD, PhD
I am a thoracic oncologist in Tenon Hospital, Paris and I collaborate with the Methods Team (INSERM- Sorbonne Paris Cité Epidemiology and Statistics Research Centre).
A graduate from Pierre and Marie Curie Medical School (2006), I completed a residency in respiratory diseases at Paris Descartes Medical School and Greater Paris Hospitals (AP-HP), and a fellow in thoracic oncology at Tenon Hospital.
I also completed an academic formation in clinical epidemiology, graduating with a MSc. (Paris Diderot University, 2010), and a PhD (Paris Descartes University, 2016).
Orcid number : 0000-0001-7836-0717
Care of lung cancer patients: investigator of several industrial and academic clinical trials (SQUIRE, INSPIRE)
Methodology of evidence synthesis in systematic review, meta-analysis and network meta-analysis
Evidence generation through the concept of live cumulative network meta-analysis
Créquit P, et al. Comparative efficacy and safety of second-line treatments for advanced non-small cell lung cancer with wild-type or unknown status for epidermal growth factor receptor: a systematic review and network meta-analysis. BMC Medicine. 2017;15(1):193.
Créquit P, et al. Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer. BMC Medicine. 2016, 14 :8.
Créquit P, et al. Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor. BMJ Open. 2016 ;6(8): e011841.
Créquit P, et al. EGFR and KRAS mutation status in non-small cell lung cancer occurring in HIV-infected patients. Lung Cancer. 2016; 96:74-7.
Créquit P, et al. Crizotinib associated with ground glass opacity predominant pattern interstitial lung disease: a retrospective observational cohort study with a systematic literature review. Journal of Thoracic Oncology. 2015; 10(8):1148-55.